|
PCGF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.131900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.909800E-02 |
| Normal-vs-Stage2 |
5.449200E-01 |
| Normal-vs-Stage3 |
1.906190E-01 |
| Normal-vs-Stage4 |
2.437900E-02 |
| Stage1-vs-Stage2 |
6.055800E-01 |
| Stage1-vs-Stage3 |
8.159600E-01 |
| Stage1-vs-Stage4 |
5.893800E-01 |
| Stage2-vs-Stage3 |
7.537200E-01 |
| Stage2-vs-Stage4 |
4.177600E-01 |
| Stage3-vs-Stage4 |
5.218200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.328100E-02 |
| Normal-vs-AfricanAmerican |
2.255600E-01 |
| Normal-vs-Asian |
1.004980E-01 |
| Caucasian-vs-AfricanAmerican |
8.369000E-01 |
| Caucasian-vs-Asian |
6.468800E-01 |
| AfricanAmerican-vs-Asian |
5.271400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.407800E-02 |
| Normal-vs-Female |
1.767830E-02 |
| Male-vs-Female |
4.685600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.837200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.208000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.874200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.127400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.535400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.529600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.484000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.965200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.646600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.831800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.111900E-02 |
| Normal-vs-Grade 2 |
4.760800E-03 |
| Normal-vs-Grade 3 |
4.085600E-01 |
| Normal-vs-Grade 4 |
6.512000E-02 |
| Grade 1-vs-Grade 2 |
8.736000E-01 |
| Grade 1-vs-Grade 3 |
2.153400E-01 |
| Grade 1-vs-Grade 4 |
7.028600E-01 |
| Grade 2-vs-Grade 3 |
1.863810E-02 |
| Grade 2-vs-Grade 4 |
6.232600E-01 |
| Grade 3-vs-Grade 4 |
1.733760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.162800E-03 |
| Normal-vs-ccB subtype |
2.164800E-01 |
| ccA subtype-vs-ccB subtype |
3.100800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.142300E-02 |
| Normal-vs-N1 |
1.158430E-01 |
| N0-vs-N1 |
8.014000E-01 |
|
|
